Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tannase-treated green tea is **green tea extract bio-transformed with the enzyme tannase**, resulting in the hydrolysis of gallated catechins such as (–)-epigallocatechin gallate (EGCG) and (–)-epicatechin gallate (ECG) into their de-gallated forms (–)-epicatechin (EC), (–)-epigallocatechin (EGC), and gallic acid (GA)[1][4][8]. This process **increases antioxidant activity** and is reported to enhance health benefits such as anti-oxidant, anti-inflammatory, anti-tumor, anti-obesity, and anti-sarcopenia effects compared to standard green tea. Mechanistically, tannase-treated green tea modulates signaling pathways involved in muscle growth and atrophy (including AMPK and mTOR/S6K), increases expression of myogenic differentiation factors (myogenin, Myf5, MyoD), and may reduce muscle wasting. It is being studied for its potential in **functional foods, nutraceuticals, and as a therapeutic supplement** for conditions like sarcopenia, oxidative stress, and metabolic disorders[1][3][5][6][7][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on tannase-treated green tea.